CollabRx

We provide solutions for evidence-based therapy selection in genomic medicine and #PrecisionOncology. Tweet us your comments about #Cancer #MentalHealth

[CollabRx @collabrx]

Most people believe that doctors are the ones who have the most responsibility/biggest impact on a patient’s medical care. Question it. Learn about PBMs and #OpioidCrisis #CancerCost #Diabetes #CostofCare #HealthCosts #MedicalBilling https://t.co/flX295q9Pn

[CollabRx @collabrx]

💡💡HUGE PARTNERS OF COLLABRX THAT YOU SHOULD KNOW

🧩With high-reputable partners, CollabRx prioritizes doing things that can help its business grow sustainably along with benefiting customers.
https://t.co/rkew0dr5Z3

#CollabRx #NFT #SiamFarm #NusaCSR #DFU

[CollabRx @collabrx]

📣HOW DOES THE ROADMAP OF COLLABRX LOOK LIKE?

🌿CollabRx always wants its customers to exactly know what is the company doing
Do not forget to keep up-to-date regularly to CollabRx by visiting the homepage website https://t.co/rkew0dr5Z3
#Collabrx #CLRX #BSC #Yahoo #Roadmap #NFT

[CollabRx @collabrx]

🏮🏮CollabRx - Proudly present OUR PARTNER
👉https://t.co/XSES5kyDfJ
#CollabRx #partner

[CollabRx @collabrx]

Thank you to Gavin Gordon and @fluidigm for the opportunity! https://t.co/1ll2AJljj0

[Standard BioTools @Standard_BioT]

Read the interview from Gavin Gordon, MBA, PhD on high content #IHC for #biomarker discovery to support precision #oncology.

https://t.co/TCtGq5MdRh

[CollabRx @collabrx]

The PBM has now become the #physician, without training, medical license, knowledge of the patient (or their illness), while making decisions highly relevant to patient’s outcomes. \#PatientExperience #Opioid #Cancer #Diabetes #HealthCosts #MedicalBilling https://t.co/flX295q9Pn

[CDC Cancer @CDC_Cancer]

January is #CervicalCancer Awareness Month! Cervical #cancer usually doesn't have symptoms, so it's critical to get screened regularly. https://t.co/b2TGHZjOPn

[#BCSM Chat @BCSMChat]

In case you missed last night's #BCSM year end wrap up: https://t.co/SHfXW8UoR7

[National Cancer Institute @theNCI]

There are different types of treatment for patients with #cervicalcancer. An overview: https://t.co/Pu7ARYSFnx #cervicalhealthmonth

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

Did you know more than 90% of cervical cancers today are caused by infection with the human papillomavirus (#HPV)? RT and learn more about the risk factors for #cervicalcancer: https://t.co/sQSLjN6hll

[george lundberg @glundberg]

Very important perspective https://t.co/Cz0I7hDzjk

[Nature Methods @naturemethods]

histoCAT software for visualization and quantitative analysis of highly multiplexed imaging data. https://t.co/pEDwFWlRnw #imagingdata

[CollabRx @collabrx]

#CancerPatients #FightCancer with knowledge: Know about PBMs and their role in non-medical switching, detrimental for some who require specific drugs/under multiple medications #oncology #MedicalBilling #PatientExperience #PrecisionMedicine #CancerCost https://t.co/flX295q9Pn

[Dr. Anthony Letai @NCIDirector]

Earlier today, my colleague @SGottliebFDA & I discussed how @theNCI & @US_FDA can find better ways to work together to make faster progress against cancer.

[george lundberg @glundberg]

How about that? Precision Radiation Oncology. https://t.co/dOHC96NFDY

[CollabRx @collabrx]

Patients: Know about how PBMs affect #diabetes and other chronic illnesses such as #cancer. #HealthCosts #MedicalBilling https://t.co/flX295q9Pn

[FDA Oncology @FDAOncology]

#FDA approval: First FDA-approved treatment for patients with germline BRCA-mutated metastatic HER2-negative metastatic #breastcancer. FDA also expanded approval of BRACAnalysis CDx test https://t.co/kI6eGvbI5g

[Dr. Anthony Letai @NCIDirector]

#2018NCIRetreat is a great opportunity for intramural researchers @NCIEpiTraining @NCIResearchCtr to discuss the results of their unique research & the future of #cancerresearch with fellow @theNCI investigators. I was pleased to join the conversation. https://t.co/NZhmcj4cWh

[CollabRx @collabrx]

#Patients: know about how PBMs (middle men corporations) control your physician’s choice…80% of drug benefits for 260 million Americans. Know why you may pay for less-effective #drugs (especially with a practice called non-medical switching). https://t.co/flX295q9Pn

[ASCO @ASCO]

Open comment for draft guideline on adjuvant chemotherapy and targeted therapy for breast cancer runs through Jan. 24. Submit feedback: https://t.co/6TUpL6va1h CC @mdmanishshah @ndenduluri1

[NIH Women's Health @NIH_ORWH]

Thanks to screenings, cervical cancer is rare in the U.S. compared to other cancers. Visit @theNCI for more info on screenings: https://t.co/vdHIoctEjR #CervicalHealthMonth